Genomics in multiple sclerosis--current state and future directions - PubMed (original) (raw)
Review
Genomics in multiple sclerosis--current state and future directions
Manuel Comabella et al. J Neuroimmunol. 2007 Jul.
Abstract
Microarray-based gene expression profiling of large numbers of genes or even the whole genome has only recently become possible. Several studies have employed this technology in multiple sclerosis (MS) and its animal model, experimental allergic encephalomyelitis (EAE), and although results are promising, microarray-based genomics research is still viewed with skepticism. It is often negatively perceived as a fishing expedition rather than a discovery-oriented effort that takes into account the immense complexity of diseases such as MS. Besides these conceptual concerns, technical reproducibility and the strategies to analyze and interpret the massive amounts of data present problems that can cause considerable variability between studies. In this review, we summarize existing data from different gene expression profiling studies that have been conducted in MS and EAE, discuss potential problems and propose future directions for the use of microarrays in MS.
Similar articles
- Intergenomic consensus in multifactorial inheritance loci: the case of multiple sclerosis.
Serrano-Fernández P, Ibrahim SM, Zettl UK, Thiesen HJ, Gödde R, Epplen JT, Möller S. Serrano-Fernández P, et al. Genes Immun. 2004 Dec;5(8):615-20. doi: 10.1038/sj.gene.6364134. Genes Immun. 2004. PMID: 15573086 - Genomics in the immune system.
van der Pouw Kraan TC, Kasperkovitz PV, Verbeet N, Verweij CL. van der Pouw Kraan TC, et al. Clin Immunol. 2004 May;111(2):175-85. doi: 10.1016/j.clim.2004.01.001. Clin Immunol. 2004. PMID: 15137950 Review. - Current gene-mapping strategies in experimental models of multiple sclerosis.
Becanovic K, Jagodic M, Wallström E, Olsson T. Becanovic K, et al. Scand J Immunol. 2004 Jul-Aug;60(1-2):39-51. doi: 10.1111/j.0300-9475.2004.01462.x. Scand J Immunol. 2004. PMID: 15238072 Review. - Transcriptional profiling of multiple sclerosis: towards improved diagnosis and treatment.
Lindberg RL, Kappos L. Lindberg RL, et al. Expert Rev Mol Diagn. 2006 Nov;6(6):843-55. doi: 10.1586/14737159.6.6.843. Expert Rev Mol Diagn. 2006. PMID: 17140371 Review. - The future of genomic profiling of neurological diseases using blood.
Sharp FR, Xu H, Lit L, Walker W, Apperson M, Gilbert DL, Glauser TA, Wong B, Hershey A, Liu DZ, Pinter J, Zhan X, Liu X, Ran R. Sharp FR, et al. Arch Neurol. 2006 Nov;63(11):1529-36. doi: 10.1001/archneur.63.11.1529. Arch Neurol. 2006. PMID: 17101821 Review.
Cited by
- Identification of potential regulatory long non-coding RNA-associated competing endogenous RNA axes in periplaque regions in multiple sclerosis.
Sabaie H, Khorami Rouz S, Kouchakali G, Heydarzadeh S, Asadi MR, Sharifi-Bonab M, Hussen BM, Taheri M, Ayatollahi SA, Rezazadeh M. Sabaie H, et al. Front Genet. 2022 Oct 17;13:1011350. doi: 10.3389/fgene.2022.1011350. eCollection 2022. Front Genet. 2022. PMID: 36324503 Free PMC article. - Autoantibodies against NMDA receptor 1 modify rather than cause encephalitis.
Wilke JBH, Hindermann M, Berghoff SA, Zihsler S, Arinrad S, Ronnenberg A, Barnkothe N, Steixner-Kumar AA, Röglin S, Stöcker W, Hollmann M, Nave KA, Lühder F, Ehrenreich H. Wilke JBH, et al. Mol Psychiatry. 2021 Dec;26(12):7746-7759. doi: 10.1038/s41380-021-01238-3. Epub 2021 Jul 30. Mol Psychiatry. 2021. PMID: 34331009 Free PMC article. - CSF SERPINA3 Levels Are Elevated in Patients With Progressive MS.
Fissolo N, Matute-Blanch C, Osman M, Costa C, Pinteac R, Miró B, Sanchez A, Brito V, Dujmovic I, Voortman M, Khalil M, Borràs E, Sabidó E, Issazadeh-Navikas S, Montalban X, Comabella Lopez M. Fissolo N, et al. Neurol Neuroimmunol Neuroinflamm. 2021 Jan 12;8(2):e941. doi: 10.1212/NXI.0000000000000941. Print 2021 Mar. Neurol Neuroimmunol Neuroinflamm. 2021. PMID: 33436375 Free PMC article. - What Have Advances in Transcriptomic Technologies Taught us About Human White Matter Pathologies?
Jäkel S, Williams A. Jäkel S, et al. Front Cell Neurosci. 2020 Aug 4;14:238. doi: 10.3389/fncel.2020.00238. eCollection 2020. Front Cell Neurosci. 2020. PMID: 32848627 Free PMC article. Review. - Engineered immunological niches to monitor disease activity and treatment efficacy in relapsing multiple sclerosis.
Morris AH, Hughes KR, Oakes RS, Cai MM, Miller SD, Irani DN, Shea LD. Morris AH, et al. Nat Commun. 2020 Aug 3;11(1):3871. doi: 10.1038/s41467-020-17629-z. Nat Commun. 2020. PMID: 32747712 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical